Stratos Wealth Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Stratos Wealth Advisors's ELV Position: Q2 2026 in Review
Stratos Wealth Advisors reduced its Elevance Health (ELV) stake by 21% in Q2 2026, selling an estimated $57.5K and leaving 585 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #579.
Stratos Wealth Advisors first reported a position in ELV in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.47M in Q4 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Stratos Wealth Advisors held 585 shares of Elevance Health worth $226K as of Q2 2026.
- Stratos Wealth Advisors sold 155 Elevance Health shares in Q2 2026, an estimated $57.5K.
- Elevance Health made up 0.01% of Stratos Wealth Advisors's portfolio in Q2 2026, its #579 holding.
- Stratos Wealth Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 17 quarters since.
- Stratos Wealth Advisors's Elevance Health position peaked at $1.47M in Q4 2022.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.